{"id":"https://openalex.org/W2120010339","doi":"https://doi.org/10.1158/1078-0432.ccr-12-3654","title":"Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors","display_name":"Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors","alternate_titles":[],"publication_year":2013,"publication_date":"2013-05-12","ids":{"openalex":"https://openalex.org/W2120010339","doi":"https://doi.org/10.1158/1078-0432.ccr-12-3654","mag":"2120010339","pmid":"https://pubmed.ncbi.nlm.nih.gov/23575478","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3694426"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-12-3654","doi":"https://doi.org/10.1158/1078-0432.ccr-12-3654","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-12-3654","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2120010339"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/articles/PMC3694426","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107936741","display_name":"Antonio Jimeno","orcid":"https://orcid.org/0000-0001-8560-0440","observed_orcids":["https://orcid.org/0000-0001-8560-0440"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Antonio Jimeno","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080669646","display_name":"Glen J. Weiss","orcid":"https://orcid.org/0000-0002-6067-597X","observed_orcids":["https://orcid.org/0000-0002-6067-597X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Glen J. Weiss","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048013287","display_name":"Wilson H. Miller","orcid":"https://orcid.org/0000-0002-7408-1574","observed_orcids":["https://orcid.org/0000-0002-7408-1574"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wilson H. Miller","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070967174","display_name":"Scott N. Gettinger","orcid":"https://orcid.org/0000-0003-0886-6880","observed_orcids":["https://orcid.org/0000-0003-0886-6880"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Scott Gettinger","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089306688","display_name":"Bernhard J. Eigl","orcid":"https://orcid.org/0000-0003-1653-6929","observed_orcids":["https://orcid.org/0000-0003-1653-6929"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernard J.C. Eigl","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044978994","display_name":"Anne Lynn S. Chang","orcid":"https://orcid.org/0000-0002-2869-2147","observed_orcids":["https://orcid.org/0000-0002-2869-2147"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne Lynne S. Chang","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075277609","display_name":"Joi Dunbar","orcid":"https://orcid.org/0009-0004-7663-1535","observed_orcids":["https://orcid.org/0009-0004-7663-1535"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joi Dunbar","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003938974","display_name":"Shannon Devens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shannon Devens","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kerrie Faia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kerrie Faia","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110142154","display_name":"Georgios P. Skliris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Georgios Skliris","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042104226","display_name":"Jeffrey L. Kutok","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeff Kutok","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010628808","display_name":"Karl D. Lewis","orcid":"https://orcid.org/0000-0001-9893-0537","observed_orcids":["https://orcid.org/0000-0001-9893-0537"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Karl D. Lewis","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018041025","display_name":"Raoul Tibes","orcid":"https://orcid.org/0000-0002-1372-8733","observed_orcids":["https://orcid.org/0000-0002-1372-8733"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raoul Tibes","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088644322","display_name":"William Howard Sharfman","orcid":"https://orcid.org/0000-0001-7766-249X","observed_orcids":["https://orcid.org/0000-0001-7766-249X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William H. Sharfman","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072869266","display_name":"Robert W. Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert W. Ross","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049524331","display_name":"Charles M. Rudin","orcid":"https://orcid.org/0000-0001-5204-3465","observed_orcids":["https://orcid.org/0000-0001-5204-3465"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I4210108457","display_name":"Infinity Pharmaceuticals (United States)","ror":"https://ror.org/01sfsq511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108457"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["CA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charles M. Rudin","raw_affiliation_strings":["Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Infinity Pharmaceuticals, Cambridge, Massachusetts","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","Stanford University, Redwood City, California","Tom Baker Cancer Center, Calgary, Alberta, Canada","Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","Yale Cancer Center, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado; 2Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; 3Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 4Yale Cancer Center, New Haven, Connecticut; 5Tom Baker Cancer Center, Calgary, Alberta, Canada; 6Stanford University, Redwood City, California; 7Infinity Pharmaceuticals, Cambridge, Massachusetts; and 8Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210134151","https://openalex.org/I5023651","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Infinity Pharmaceuticals, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210108457"]},{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Stanford University, Redwood City, California","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tom Baker Cancer Center, Calgary, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona","institution_ids":[]},{"raw_affiliation_string":"Yale Cancer Center, New Haven, Connecticut","institution_ids":["https://openalex.org/I2802730090"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5107936741"],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801824472","https://openalex.org/I2802730090","https://openalex.org/I4210108457","https://openalex.org/I4210134151","https://openalex.org/I4210164401","https://openalex.org/I5023651","https://openalex.org/I51713134","https://openalex.org/I97018004"],"apc_list":null,"apc_paid":null,"fwci":7.4457,"has_fulltext":false,"cited_by_count":186,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98570181,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"19","issue":"10","first_page":"2766","last_page":"2774"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12009","display_name":"Hedgehog Signaling Pathway Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12009","display_name":"Hedgehog Signaling Pathway Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12065","display_name":"Hippo pathway signaling and YAP/TAZ","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vismodegib","display_name":"vismodegib","score":0.843999981880188},{"id":"https://openalex.org/keywords/hedgehog-pathway-inhibitors","display_name":"Hedgehog pathway inhibitors","score":0.9139999747276306},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8489999771118164},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9279999732971191},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9959999918937683},{"id":"https://openalex.org/keywords/basal-cell-carcinoma","display_name":"basal cell carcinoma","score":0.9049999713897705},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7749999761581421},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.7829999923706055},{"id":"https://openalex.org/keywords/accelerated-titration","display_name":"accelerated titration","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7296586036682129},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.666141152381897},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6080266237258911},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5742565393447876},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5497607588768005},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4717821776866913},{"id":"https://openalex.org/C2777513400","wikidata":"https://www.wikidata.org/wiki/Q104219","display_name":"Bilirubin","level":2,"score":0.46699586510658264},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4597158432006836},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4548608958721161},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4482465386390686},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4115690290927887},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3270360231399536}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000410","descriptor_name":"Alanine Transaminase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000505","descriptor_name":"Alopecia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001219","descriptor_name":"Aspartate Aminotransferases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013035","descriptor_name":"Spasm","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D014704","descriptor_name":"Veratrum Alkaloids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014704","descriptor_name":"Veratrum Alkaloids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014704","descriptor_name":"Veratrum Alkaloids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053823","descriptor_name":"Hedgehog Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-12-3654","doi":"https://doi.org/10.1158/1078-0432.ccr-12-3654","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-12-3654","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:23575478","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23575478","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:europepmc.org:2688053","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3694426","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3694426","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3694426/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2688053","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3694426","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G9000858110","display_name":"Targeting PD-L1 interactome signaling to enhance immunotherapy efficacy in head and neck squamous cell cancer","funder_award_id":"R01CA149456","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000911005","display_name":"Regional Oncology Research Center","funder_award_id":"P30CA006973","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1965431780","https://openalex.org/W1970960957","https://openalex.org/W1986404157","https://openalex.org/W1988361598","https://openalex.org/W1990453562","https://openalex.org/W1997379399","https://openalex.org/W1997632957","https://openalex.org/W2023028445","https://openalex.org/W2050091384","https://openalex.org/W2055296003","https://openalex.org/W2070288993","https://openalex.org/W2084381245","https://openalex.org/W2086152184","https://openalex.org/W2096156234","https://openalex.org/W2107441200","https://openalex.org/W2108707301","https://openalex.org/W2116831767","https://openalex.org/W2125923072","https://openalex.org/W2126152795","https://openalex.org/W2139248078","https://openalex.org/W2139499843","https://openalex.org/W2151089236","https://openalex.org/W2153889566","https://openalex.org/W2156560090","https://openalex.org/W4229861519"],"related_works":["https://openalex.org/W2510676179","https://openalex.org/W2560642681","https://openalex.org/W2137957847","https://openalex.org/W2335259743","https://openalex.org/W2236482561","https://openalex.org/W2334958964","https://openalex.org/W2394708299","https://openalex.org/W2119147333","https://openalex.org/W2778187137","https://openalex.org/W2335017796"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"conduct":[2],"a":[3,25,151,159,191,204,211],"first-in-human":[4],"phase":[5,238],"I":[6],"study":[7],"to":[8,42,102,109,213,225],"determine":[9],"the":[10,15,20,31,236],"dose-limiting":[11],"toxicities":[12],"(DLT),":[13],"characterize":[14],"pharmacokinetic":[16],"profile,":[17],"and":[18,62,84,110,131,136,158,165,189,241],"document":[19],"antitumor":[21],"activity":[22,247],"of":[23,87,121,187,207,248],"IPI-926,":[24],"new":[26],"chemical":[27],"entity":[28],"that":[29],"inhibits":[30],"Hedgehog":[32],"pathway":[33],"(HhP).":[34],"EXPERIMENTAL":[35],"DESIGN:":[36],"Patients":[37],"with":[38,143,176,256],"solid":[39],"tumors":[40],"refractory":[41],"standard":[43,70],"therapy":[44],"were":[45,76,79,116,148],"given":[46],"IPI-926":[47,139,146,188,214,220,249],"once":[48],"daily":[49],"(QD)":[50],"by":[51,150],"mouth":[52],"in":[53,124,198,252],"28-day":[54,230],"cycles.":[55],"The":[56],"starting":[57],"dose":[58,186,240],"was":[59,67,140,221,233,250],"20":[60,101,164],"mg,":[61],"an":[63],"accelerated":[64],"titration":[65],"schedule":[66,242],"used":[68],"until":[69],"3":[71,73],"+":[72],"dose-escalation":[74],"cohorts":[75],"implemented.":[77],"Pharmacokinetics":[78],"evaluated":[80],"on":[81],"day":[82,85],"-7":[83],"22":[86],"cycle":[88],"1.":[89],"RESULTS:":[90],"Ninety-four":[91],"patients":[92,175,255],"(32F,":[93],"62M;":[94],"ages,":[95],"39-87)":[96],"received":[97,182],"doses":[98,216],"ranging":[99],"from":[100],"210":[103],"mg":[104,113,227],"QD.":[105],"Dose":[106],"levels":[107],"up":[108,224],"including":[111],"160":[112,226],"administered":[114],"QD":[115,169,228],"well":[117,222],"tolerated.":[118],"Toxicities":[119],"consisted":[120],"reversible":[122],"elevations":[123],"aspartate":[125],"aminotransferase":[126,129],"(AST),":[127],"alanine":[128],"(ALT)":[130],"bilirubin,":[132],"fatigue,":[133],"nausea,":[134],"alopecia,":[135],"muscle":[137],"spasms.":[138],"not":[141],"associated":[142],"hematologic":[144],"toxicity.":[145],"pharmacokinetics":[147],"characterized":[149],"slow":[152],"absorption":[153],"(T(max)":[154],"=":[155],"2-8":[156],"hours)":[157],"terminal":[160],"half-life":[161],"(t(1/2))":[162],"between":[163],"40":[166],"hours,":[167],"supporting":[168],"dosing.":[170],"Of":[171],"those":[172],"HhP":[173,253],"inhibitor-na\u00efve":[174,254],"basal":[177],"cell":[178],"carcinoma":[179],"(BCC)":[180],"who":[181],"more":[183],"than":[184],"one":[185],"had":[190],"follow-up":[192],"clinical":[193],"or":[194],"Response":[195],"Evaluation":[196],"Criteria":[197],"Solid":[199],"Tumors":[200],"(RECIST)":[201],"assessment,":[202],"nearly":[203],"third":[205],"(8":[206],"28":[208],"patients)":[209],"showed":[210],"response":[212],"at":[215],"\u2265130":[217],"mg.":[218],"CONCLUSIONS:":[219],"tolerated":[223],"within":[229],"cycles,":[231],"which":[232],"established":[234],"as":[235],"recommended":[237],"II":[239],"for":[243],"this":[244],"agent.":[245],"Single-agent":[246],"observed":[251],"BCC.":[257]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2120010339","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":36},{"year":2014,"cited_by_count":24},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
